hero section gradient
10 handpicked stocks

Beauty

These beauty stocks represent leading companies in skincare, haircare, and makeup. Carefully selected by our analysts, these investments offer exposure to a growing global industry expected to reach $716.6 billion by 2025.

Author avatar

Han Tan | Market Analyst

Published on May 21

Your Basket's Financial Footprint

Market capitalisation breakdown for the 'Beauty' basket and concise investor key takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and performance that tends to track broader market moves.
  • Use as a core, long-term holding rather than a speculative or high-growth allocation.
  • Likely suited for steady, long-term value rather than rapid, short-term gains.
Total Market Cap
  • PG: $354.86B

  • JNJ: $462.30B

  • UL: $151.93B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The beauty industry combines creativity, science, and business in a rapidly growing market. With expanding middle-class populations worldwide, there's increasing demand for skincare, haircare, and makeup products, including natural and organic options.

2

What You Need to Know

Beauty stocks represent companies that create personal care products used by millions daily. This industry is expected to grow 6% annually until 2027, driven by consumer loyalty to trusted brands and increasing global demand for beauty and self-care products.

3

Why These Stocks

These stocks were handpicked to represent established beauty leaders and innovative players across different market segments. They include major household names that make the products people use every day, giving you investment exposure to a resilient and growing industry.

Why You'll Want to Watch These Stocks

💄

Beauty Never Goes Out of Style

Beauty products are part of daily routines worldwide, creating consistent consumer demand even during economic downturns. This resilience makes beauty stocks worth watching for long-term potential.

📈

Massive Market Growth Ahead

With the global beauty market projected to reach $716.6 billion by 2025, these companies are positioned in one of the fastest-growing consumer sectors. The expanding middle class worldwide means more customers every day.

🌿

Riding the Natural Products Wave

Consumer preferences are shifting toward natural and organic beauty products. These companies are adapting to meet this demand, potentially opening new revenue streams and market opportunities.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions